Investing.com -- Piper Sandler downgraded Biogen Inc (NASDAQ:BIIB) from “overweight” to “neutral,” given a challenging transition period for the biotech firm. The brokerage hacked the ...
MINNEAPOLIS--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, will release its fourth quarter and full year 2024 financial results prior to the opening of the ...
Piper Sandler downgrades Biogen, slashes PT by $177 amid transition challenges Tesla deliveries miss expectations, stock drops 4% Goldman Sachs adds Norwegian Cruise Line, Uber to US conviction list ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback